DLA Piper LLP (US)

Co-headed from New York and Los Angeles by John Clarke and Melanie Walker, respectively, DLA Piper LLP (US)‘ securities litigation offering acts on its own as well as frequently alongside lawyers from complementary firmwide practice areas, including corporate, regulatory, and white-collar, to provide a holistic service to corporates and their directors and officers, defending against private securities class actions, derivative shareholder actions and parallel agency investigations. Although the team has a fairly broad sector offering, it is particular active representing life sciences, financial services and tech clients, with Clarke recently securing a number of notable victories for global life sciences company, Bristol-Myers Squibb, in litigation concerning a series of publicly traded contingent value rights which became worthless upon failing to receive FDA approval for a milestone drug in time. Walker’s broad-ranging litigation practice includes accountant’s liability cases, while on the core securities litigation front she has recently handled a number of high-profile de-SPAC cases. Seasoned trial and appellate lawyer John Hillebrecht in New York and Dallas-based former SEC attorney Jason Lewis are also key contacts.